Recherche
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
(Science Immunology. vol. 6, n° 62, 2021-08-19)Article de revueLibre accès -
Stroke genetics informs drug discovery and risk prediction across ancestries
(Nature. pp. 1-15, 2022-09-30)Article de revueLibre accès -
Contribution of Common Genetic Variants to Risk of Early Onset Ischemic Stroke
(Neurology. vol. 99, n° 16, 2022-08-31)Article de revueLibre accès -
Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke
(Stroke. vol. 53, n° Suppl_1, 2022-02)Article de revue -
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
(Nature. vol. 612, n° 7938, 2022-12)Article de revueLibre accès -
Stroke Genetics, Genomics, and Precision Medicine
(Stroke, 2024-03-21)Article de revue -
Multiomic approaches to stroke: the beginning of a journey
(Nature Reviews Neurology. vol. 20, n° 2, pp. 65-66, 2024-02-01)Article de revue